The psychopharmacology of agitation: consensus statement of the american association for emergency psychiatry project Beta psychopharmacology workgroup
- PMID: 22461918
- PMCID: PMC3298219
- DOI: 10.5811/westjem.2011.9.6866
The psychopharmacology of agitation: consensus statement of the american association for emergency psychiatry project Beta psychopharmacology workgroup
Abstract
Agitation is common in the medical and psychiatric emergency department, and appropriate management of agitation is a core competency for emergency clinicians. In this article, the authors review the use of a variety of first-generation antipsychotic drugs, second-generation antipsychotic drugs, and benzodiazepines for treatment of acute agitation, and propose specific guidelines for treatment of agitation associated with a variety of conditions, including acute intoxication, psychiatric illness, delirium, and multiple or idiopathic causes. Pharmacologic treatment of agitation should be based on an assessment of the most likely cause of the agitation. If agitation results from a delirium or other medical condition, clinicians should first attempt to treat the underlying cause instead of simply medicating with antipsychotics or benzodiazepines.
Conflict of interest statement
Figures
References
-
- Battaglia J. Pharmacological management of acute agitation. Drugs. 2005;65:1207–1222. - PubMed
-
- Currier GW, Trenton A. Pharmacological treatment of psychotic agitation. CNS Drugs. 2002;16:219–228. - PubMed
-
- MacDonald K, Wilson MP, Minassian A, et al. A retrospective analysis of intramuscular haloperidol and olanzapine in the treatment of agitation in drug- and alcohol-using patients. Gen Hosp Psychiatry. 2010;32:443–445. - PubMed
-
- Vilke GM, Wilson MP. Agitation: what every emergency physician should know. Emerg Med Rep. 2009;30:233–244.
-
- Hill S, Petit J. The violent patient. Emerg Med Clin North Am. 2000;18:301–315. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical